Alimera Sciences, Inc. announced that the company has added Michael Kaseta and Adam Morgan, to its Board of Directors, as designees of Caligan Partners and Velan Capital, respectively. Prior to these appointments, long-term board member, former Chairman and lead independent director James Largent, and recently appointed Roger Sawhney, resigned as directors. Mr. Kaseta has served as Chief Financial Officer (CFO) at Liquidia Corporation since December 2020.

Mr. Kaseta has previously held CFO positions at Aerami Therapeutics, Aralez Pharmaceuticals and Sanofi where he spent eleven years in a variety of financial roles before being appointed CFO at Sanofi SA for North America Global Services and the North America Pharmaceutical Region. Mr. Kaseta holds a BBA in accounting from James Madison University and is a CPA (inactive) licensed in the state of New Jersey. Mr. Morgan currently serves as the Chief Investment Officer of Velan Capital Investment Management LP, a healthcare-dedicated investment firm based in Alpharetta, Georgia.

Mr. Morgan also currently serves on the board of directors of Health Outlook Corporation, a privately-held developer of predictive healthcare technology and service based in New York, New York, where he serves as a director and chair of the company's audit committee, and Heron Therapeutics, Inc., a publicly-listed biotechnology company focused on advancing the standard of care for acute and oncology patients, where he serves as a director and member of the nomination and governance committee. Mr. Morgan received his B.S. in chemistry from the University of Minnesota and his M.B.A. from the Carlson School of Management at the University of Minnesota.